FDA errs on halting genetic testing
12/11/2013 10:10 AM
12/11/2013 9:59 AM
Re "FDA is correct to halt genetic tests from 23andMe" (Editorials, Dec. 7): The U.S. Food and Drug Administration is busily expanding its power over medical drugs and equipment to include the practice of medicine by individual physicians. The agency's obsession is to make sure that no one is allowed to get well without its permission. One glaring example is the FDA’s legal action against physicians who remove stem cells from a patient to treat that patient. A person's own stem cells are a chemical that only the FDA is permitted to regulate is what the agency is saying in court. For years, the FDA has tried to prevent journals from publishing information about the effectiveness of certain drugs. Now, the FDA pulls the plug using a person's own genetic information. This is about bureaucrats defending their own power, not health care.
-- Richard E. Ralston, Newport Beach, executive director, Americans for Free Choice in Medicine
Editor's Choice Videos
Join the Discussion
The Sacramento Bee is pleased to provide this opportunity to share information, experiences and observations about what's in the news. Some of the comments may be reprinted elsewhere on the site or in the newspaper. We encourage lively, open debate on the issues of the day, and ask that you refrain from profanity, hate speech, personal comments and remarks that are off point. Thank you for taking the time to offer your thoughts.